5'-AMP-Activated Protein Kinase Catalytic Subunit Alpha-2 (PRKAA2) Peptide

Product Graph
195€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
5'-AMP-Activated Protein Kinase Catalytic Subunit Alpha-2 (PRKAA2) Peptide
category
Proteins and Peptides
provider
Abbexa
reference
abx616346
tested applications
P-ELISA

Description

5'-AMP-Activated Protein Kinase Catalytic Subunit Alpha-2 (PRKAA2) Peptide is a synthetic peptide. This peptide is used in the production of

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
5'-AMP-Activated Protein Kinase Catalytic Subunit Alpha-2 (PRKAA2)
Host
Synthetic
Assay Type
Activity: Not tested.
Sequence Fragment: Internal region: CPLDALNTTKP
Recommended Dilution
BL (predicted): 0.5 mg/ml. Optimal dilutions/concentrations should be determined by the end user.
Conjugation
Unconjugated
Size 1
100 µg
Form
Lyophilized
Tested Applications
P-ELISA
Buffer
Prior to lyophilization: Deionized water.
Availability
Shipped within 5-10 working days.
Storage
Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Gene ID
5563, 108079, 78975
NCBI Accession
NP_006243.2
Background
Protein PRKAA2
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Reconstitute in deionized water.

Descripción

Related Products

EH1140

Human PRKAA2 (5'-AMP-activated protein kinase catalytic subunit alpha-2) ELISA Kit

Ver Producto
FNab00376

PRKAA2 antibody

PRKAA2(protein kinase, AMP-activated, alpha 2 catalytic subunit), also named as AMPKA2, AMPK, PRKAA, AMPK2, belonogs to the CAMK Ser/Thr protein kinase family and SNF1 subfamily. PRKAA2 is an αβγ heterotrimer that is activated by low cellular energy status, such as decreases in both the ATP/AMP ratio and the phosphocreatine content and it is a glycogen synthase kinase, phosphorylating Ser7 at the NH2 terminus, which decreases glycogen synthase activity(PMID:14532170). The protein can be ubiquitinated(PMID:21224036).

Ver Producto
P0340

Recombinant Human PRKAA2

Ver Producto